XTRA:RDCConsumer Retailing
Redcare Pharmacy (XTRA:RDC): Assessing Valuation Following 2025 Sales Growth Guidance and Renewed Investor Optimism
Redcare Pharmacy (XTRA:RDC) confirmed its full-year 2025 guidance and anticipates sales growth of over 25%. This latest outlook signals continued expansion and has drawn renewed interest from investors watching the company’s trajectory.
See our latest analysis for Redcare Pharmacy.
After a volatile stretch for Redcare Pharmacy, the company’s confirmed guidance and robust sales outlook appear to have sparked renewed enthusiasm, as seen in the sharp 7.01% jump in share price today. Looking at...